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III. Abstract 
 
Embryonic stem cells are unique in their ability to grow indefinitely while maintaining 
both pluripotency and self-renewal capabilities. These stem cells could be the answer to 
solving many of the debilitating and devastating diseases suffered by humans. Recently, 
the use of human derived embryonic stem cells has been effective in animal models in the 
treatment of spinal cord injuries (Kierstead et al., 2005). Although the study of embryonic 
stem cells has become increasingly popular in the last decade, there is still much research 
to be done to increase the expression of valuable embryonic proteins which will induce 
pluripotency in the cell. These proteins have been found to reprogram murine somatic 
cells into induced pluripotent stem (iPS) cells (Takahashi and Yamanaka, 2006). 
Research conducted in the last decade has revealed four transcription factors which are 
vital to the induction of pluripotency in differentiated cells. iPS cells are derived using 
these purified proteins through protein transfection. 
This study focused on four of these transcription factors, Oct4, Sox2, Myc, and 
Klf4. Although each of these factors has different functions many of them act 
synergistically to promote pluripotency and self-renewal. To increase the expression of 
these transcription factors by a host cell, Escherichia coli, genes for the chaperone 
protein and transcription factors are induced using combinations of tetracycline and L-
arabinose.  Chaperone plasmids increase protein folding and the ability of the host to 
express foreign DNA. The purpose of this study was to combine the four transcription 
factors with one of the two chaperone plasmids, pG-Tf2 and pG-KJE8 which have been 
given different inducers to determine which combination for each transcription factor has 
the highest expression. In order to determine this, bacterial host cell colonies were raised 
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to contain one of the four factors. Each colony was raised with one of the two chaperone 
plasmids. Colonies which contained the pG-Tf2 plasmid were induced using tetracycline 
only since they only contained one promoter region. Colonies containing the pG-KJE8 
plasmid were induced with either tetracycline, L-arabinose or both since it contains two 
promoter regions. When the pG-Tf2 chaperone plasmid was used there was positive 
expression in the Sox2 colonies but no expression was seen in the soluble fraction of any 
other colony. pG-KJE8 induced with only tetracycline had no expression in any colony. 
Induction with L-arabinose produced a positive result in the Sox2 and Oct4 colonies. 
When pG-KJE8 was induced with tetracycline and L-arabinose there was no expression 
in the soluble fraction from any colony. None of the four conditions tested provided any 
response in the soluble fraction from Myc or Klf4 indicating the need for further research 
on the best conditions for expression of these proteins. 
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IV. Introduction 
 
Embryonic stem (ES) cells hold the future of treating many disorders such as 
Parkinson’s disease, spinal cord injuries and other debilitating disorders many Americans 
live with every day (Thomson et al., 1998). Derived from the inner cell mass (ICM) of 
the mammalian blastocysts, ES cells are pluripotent, i.e., they can differentiate into any 
one of the three germ layers. Although the use of human embryonic stem cells is much 
contested, recent research has focused on the potential to use somatic cells fused with ES 
cells to induce pluripotency in the somatic cell (Kazutoshi and Shinya, 2006). Stem cells 
are also capable of self-maintenance and self replacement. They divide asymmetrically 
and produce other stem cells which are pluripotent and undifferentiated (Katz et al., 
2002).  
Takahashi and Yamanaka (2006) demonstrated that induction of pluripotent stem 
cells can be achieved through the use of transcription factors in both mouse embryonic 
and adult fibroblasts. Their study provides groundbreaking research into the importance 
of the transcription factors used in this study. Although previous research (Katz et al., 
2002, Nichols et al., 1998, and others) has indicated the importance of certain factors, it 
was not until the study by Takahashi and Yamanaka (2006) that the value of these factors 
was truly tested. Takahashi and Yamanaka (2006) began with 24 potential genes that 
could be used to create iPS cells from somatic cells. However, after the systematic 
knockout of each factor, it was determined that there were four factors that played vital 
roles and no pluripotency could be created without them.    
The transcription factors of interest in this study, and the ones determined to be 
important by Takahashi and Yamanaka (2006), are Oct 4, Sox2, MYC and Klf4. Oct 4 
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(also known as Oct3, Rosner et al., 1990) is a POU domain-containing transcription 
factor which is encoded by Pou5f (Loh et al., 2006). POU factors promote cell 
proliferation both directly and indirectly (Nichols et al. 1998). Several studies (Loh et al., 
2006; Nichols et al., 1998) have identified this transcription factor as an essential factor 
in the maintenance of pluripotency in the early embryo and germ cells. Oct4 is a key 
regulator in the formation of the inner cell mass during preimplantation development 
(Loh et al., 2006). The ICM develops into the pluripotent cells of nontrophoblast 
extraembryonic tissues. The ICM has high stem cell populations which can be adapted to 
a variety of conditions. These stem cells will remain pluripotent through late gastrulation 
(Nichols et al., 1998). Oct4 is required for the first cell fate (Avilion et al., 2003). Oct4 is 
distinguished by its exclusive expression in the blastomere and its pluripotent early 
embryonic cells (Rosner et al., 1990). Oct4-/- embryos will develop to a blastocyst stage 
but the ICM cells are not pluripotent. These cells are placed into the extraembryonic 
trophoblast lineage of which descendents are restricted to this generation (Nichols et al. 
1998). Oct4 can regulate the expression of multiple genes through its interaction with 
another transcription factor that is also present in pluripotent cells (Nichols et al., 1998). 
Sox2 (SRY- related HMG box), is a member of the gene family that includes testis-
determining factor (Yuan et al., 1995; Maruyama et al., 2005). In the developing embryo, 
Sox2 RNA can first be detected in the morula stage and is specifically seen in the ICM of 
the blastocyst. Sox2 identifies the pluripotent lineage in the mouse embryo and is 
associated with the uncommitted stem and precursor cells of the central nervous system 
(Avilion et al., 2003). Sox2 and its association with Oct4 are absolutely essential for the 
establishment of pluripotency in embryonic cells (Maruyama et al., 2005; Yuan et al., 
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1995). Sox proteins are highly conserved high mobility group (HMG) domains that are 
involved in DNA recognition and binding. Sox2 plays an essential role in cell 
differentiation, development and organogenesis (Maruyama et al., 2005). In the absence 
of Sox2 cells change their identity and do not remain in the undifferentiated state 
(Avilion et al., 2003) Sox2 can form a ternary complex with Oct4 and can promote 
transcriptional activation (Yuan et al., 1995). Sox2 binds to AACAA(A/T)G while Oct4 
binds to ATT(A/T)GCAT. Embryos that are Sox2- and Oct4- null are lethal in the peri-
implantation stages indicating that Sox2 and Oct4 are essential to maintain pluripotency 
in embryonic stem cells (Maruyama et al., 2005) In the early embryo, the expression of 
these two transcription factors overlap in the morula, ICM, epiblast and germ cells 
suggesting they have a parallel role in pluripotency (Avilion et al., 2003).  
 The third transcription factor, Myc, has been implicated in the development of 
many human tumors. Elevated Myc expression has bee known to contribute to 
tumorigenesis and has long been implicated in unrestricted cell proliferation and the 
inhibition of cell differentiation (Adhikary and Eilers, 2005). Other studies (Domashenko 
et al., 1997) have indicated that the Myc gene family is essential for preimplantation 
development. It has been estimated that Myc may be bound to approximately 25,000 sites 
in the human genome where it regulates a significant portion of all genes in an organism 
(Adhikry and Eilers, 2005). Gene knockout experiments revealed that these genes are 
absolutely essential for embryogenesis however; a lack of one member of the Myc family 
does not effect preimplantation development leading to the thought that members of the 
family may have overlapping roles (Domashenko et al., 1997). The Myc genes can both 
activate transcription and repress it depending on its binding location. Myc that binds to 
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the DNA recognition sequence (CACA/GTG) will activate transcription while binding to 
the promoter, Miz1, will repress transcription (Adhikry and Eilers, 2005). 
 Klf4, Krüppel-like factor 4, is a transcription factor which is expressed in the 
epithelia of the skin, lungs, gastrointestinal tract as well as several other organs. Klf4 is 
reported to play a vital role in both cell proliferation and differentiation (Katz et al., 
2002). Klf4 can activate and repress genes that are involved in cell cycle regulation and 
differentiation and levels of this transcription factor rise following DNA damage 
(Rowland et al., 2005). Mice that lack the Klf4 gene die within 15 hours of birth and have 
mutations in late-stage differentiation (Katz et al., 2002). Klf4 can switch from a growth-
inhibiting tumor suppressor to a growth-promoting oncogene depending on the presence 
or absence of unidentified factors (Rowland et al., 2005).   
 Previously, many studies have used a virus or plasmid to express the transcription 
factors; however, both methods carry a risk of genomic integration and thus disruption of 
gene expression. The study completed by Takahashi and Yamanaka (2006) retrovirally 
introduced the genes that encoded the transcription factors. This study will use proteins to 
induce expression which theoretically carry no risk of alteration in the genomic sequence 
of the iPS cell. Zhou et al. (2009) also used recombinant cell-penetrating reprogramming 
proteins and had great success in the creation of iPS cells from murine embryonic 
fibroblasts. 
In order to increase the ability of Escherichia coli to express the foreign 
transcription factors chaperone coexpression plasmids are added to the bacteria. DnaK-
DnaJ-GrpE and GroEL-GroES are the most common chaperone proteins used to assist 
the host cell in protein folding and decrease the incidence of inclusion bodies (Nishihara 
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et al., 1998). Without the addition of chaperone proteins, proteins in E.coli are often 
rapidly degraded or have an inability to form their native tertiary structures (Nishihara et 
al., 1998). Molecular chaperones suppress aggregation reactions and increase proper 
folding through ATP-coordinated cycles (Thomas et al., 1997). 
 The purpose of this study was to find the best combination of transcription factor 
with chaperone protein inducer. Chaperone plasmids such as pG-KJE8, which was used 
in this study, can be induced to express different chaperone proteins depending on the 
type of inducer used in the media. In some chaperone plasmids, there are two promoter 
regions which are activated with different inducers. By inducing a different promoter, a 
different chaperone within the plasmid can be activated. Of the two chaperone plasmids 
used in this study, only pG-KJE8 contains two promoters which will be induced 
separately and then jointly to test its effectiveness. pG-Tf2 will only be tested with one 
since it contains a single promoter region.  This study will look at four conditions; 
1. Chaperone plasmid pG-Tf2 induced with tetracycline 
2. Chaperone plasmid pG-KJE8 induced with tetracycline 
3. Chaperone plasmid pG-KJE8 induced with L-arabinose 
4. Chaperone plasmid pG-KJE8 induced with L-arabinose and 
tetracycline 
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V. Materials and Methods 
 
Bacterial strain  
E.coli BL21 strain DE3 [hsdSB(rB-mB) gal dcm (DE3)] was purchased from 
Novagen® (Darmstadt, Germany).  BL21DE3 is commonly chosen as a host for protein 
expression since it is deficient in both the lon, and ompT proteases. The lon protease is 
ATP-dependent and stabilizes some foreign proteins while a lack of ompT indicates a 
lack of outer membrane proteases which can improve the recovery of the recombinant 
proteins. The DE3 indicates that this host strain contains a lambda prophage. In this strain 
the gene for T7 RNA polymerase is under the control of the lacUV5 promoter.  
Chaperone Plasmids 
Table 1. 
    Chaperone Plasmids 
Plasmid Chaperone Promoter Inducer Resistant 
Marker 
pG-KJE8 dnaK-dnaJ-grpE 
groES-groEL 
araB 
Pzt1 
L-Arabinose 
Tetracycline 
Cm 
pG-Tf2 groES-groEL-tig Pzt1 Tetracycline Cm 
 
 All cell cultures were initially inoculated in a LB medium containing 20 µg/ml 
chloramphenicol and 50 µg/ml ampicillin for plasmid selection. In condition one, the 
chaperone plasmid pG-KJE8 was used along with 0.5 mg/ml of L-arabinose to induce the 
araB promoter. For the second condition, 5 ng/ml of Tetracycline was added to induce 
the Pzt1 promoter. Both promoters are present in pG-KJE8 and are tested separately to 
determine any differences. Condition three will test the combined effects of L-arabinose 
and Tetracycline on protein expression. When pG-Tf2 was used instead of pG-KJE8, as 
in condition four, only Tetracycline was added to the plate to induce the Pzt1 promoter 
region for the groES-groEL-tig chaperone for protein expression 
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Figure 1. Structure of chaperone coexpression plasmids pG-KJE8 (a) and pG-Tf2 (b). 
a. b.  
 
ori, replication origin of pACYC, tetR, tetR repressor gene, Cmr, chloramphenicol 
resistance, araC, araC repressor gene, araB, promoter-operator 
 
 
Bacterial Transformation 
 
Transformation was completed following the protocol provided by Novagen® 
(Darmstadt, Germany). Cells were thawed and mixed gently to ensure they were evenly 
suspended and 20 µl aliquots of cells were placed in pre-chilled tubes. 1 µl of DNA 
solution was added. Tubes were heated for 30 seconds in 42oC water bath and then placed 
on ice for two minutes. Prior to this, 0.5 µl of one chaperone plasmid was fused with 0.5 
µl one of the four transcription factors studied, Oct-4, Sox-2, MYC, and KLF4 and 
referred to as ON (Oct-4, N terminal), SN (Sox-2, N terminal), MN (MYC, N terminal), 
and KN (KLF 4, N terminal). 
 
Bacterial Induction and Extraction 
Bacterial induction was completed following a slow induction protocol prepared 
by Arur and Nayak (See attached protocol). Colonies were selected and grown overnight 
at 30oC in LB + AMP + Chloramphenicol in a 15 ml snap cap on a shaker. The solution 
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was diluted to 1:50 in 2 ml of LB+AMP+Chloramphenicol and grown for 3-4 hours at 37 
oC. One ml of LB + AMP + Chloramphenicol +1 mM IPTG was prepared and 
prewarmed to 37 oC prior to use. After 3-4 hours, 1 ml was removed from tubes and spun 
at maximum x g for 30 sec at room temperature. The supernatant was removed and the 
pellet frozen at -20 oC. A slow induction of protein expression was chosen to enhance 
solubility. 1 ml of LB + AMP + Chloramphenicol+ 1 mM IPTG at 19 oC was added and 
incubated at 19 oC for 12 hours. The final concentration of IPTG was 0.5 mM. One ml 
from the induced sample was transferred and spun at max for 30 seconds at room 
temperature and the supernatant was removed. Cells were frozen at -20 oC until needed 
later. 
To extract the proteins 1 ml of the bacteria was spun at 1200 x g for 30 seconds at 
room temperature. An extractor buffer, xTractor buffer from clontech laboratories, was 
created from 2 ml of xTractor buffer, 2.5 µl of DNAse, 20 µl of lysosome (1 mg/ml) and 
2 µl of PMSF. The pellet is resuspended and rocked at room temperature for 15 minutes 
and then spun at 12000 x g for 20 minutes at 4oC. The supernatant is then saved at put on 
ice while the pellet is resuspended with 200 µl of 2% SDS and heated to 95oC for 10 
minutes. In additional tubes, 10 µl of 5x reducing buffer and 40 µl of the pellet or 
supernatant were added. All tubes were heated at 95oC for 10 minutes and then spun for a 
short spin.  
 
Protein Expression Analysis and Quantification 
Gels for electrophoresis were created using the standard protocol for 10% 
resolving gel (4.9ml DDI H20, 2.5 ml 30% degassed Acrylamide/Bis, 2.5 ml gel buffer, 
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0.1ml 10% SDS, 100µl APS and 10µl of TEMED. 1.5 M Tris-HCl (pH 8.8) was used as 
the gel buffer. A 4% stacking gel was used (6.4ml DDI H2O, 1ml 30% Degassed 
Acrylamide/Bis, 2.5ml gel buffer, 0.1ml 10% SDS, 100µl APS dilution and 10µl of 
TEMED). Proteins were loaded at 15µl per sample and 10µl of marker. Samples were run 
for 37 minutes at 200 v and were transferred to a membrane soaked in Methanol. These 
were run in TGS buffer at room temperature over night at 120 mA.  
Protein expression was analyzed using the Universal His Western Blot Kit 2.0 
Protocol from Clontech Laboratories. Instead of using PBST1 buffer as recommended, 
TBST (10 mM Tris (pH 7.5), 100 mM NaCl and 0.1% Tween 20) buffer was used for the 
first wash for 30 minutes. TBST was used rather than the recommended buffer based on 
previous experience from Yong Tang, and its ability to produce the same quality signal 
and a clean background for quantification. The primary buffer, His-Detection Reagent, 
was diluted with 1µl of reagent and 99 µl of 0.9% NaCl. The secondary antibody, 
Streptavidin-HRP, was diluted with 1 µl of Streptavidin-HRP in 99 µl of PBST3. 
Following the end of the protocol the blots were placed protein side up in a 
chemiluminescence film cassette and put through a film development process to expose 
the proteins to the chemiluminescence film. These films were placed on a docucam and 
the QuantityOne software from Biorad was used to reduce the backgrounds and quantify 
the volume of the bands. This volume was adjusted for the volume of the background and 
the adjusted volumes were used to compare the intensity of protein expression. 
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VI: Results: 
 
pG-Tf2 
 
Western blot analysis of the four transcription factors SN, ON, KN, MN revealed that 
while tetracycline is the preferred inducer for the Pzt1 promoter region on pG-Tf2, there 
were few positive results when used with these factors. Of the four transcription factors, 
tetracycline induction of the pG-Tf2 chaperone plasmid produced the best result in the 
SN colonies as seen in Table 2 and 3. 
 
Table 2.  pG-Tf2 
 
SN 1 Colony 
Gel 1 
 
 
pG-Tf2 
Blank 
pG-Tf2 
No Chaperone 
pG-Tf2 
Tet induced 
pG-KJE8 
Tet induced 
PELLET -- + + + + + + 
SOLUBLE -- -- + -- 
 (above) Expression 
strength of bands using 
adjusted volume from 
Western Blot test in the 
SN1 Colony of E. coli 
bacteria. See below for 
key (left) Figure 2. 
Western Blot printout of 
the SN1 colony using 
QuantityOne computer 
program to quantify the 
strength of expression 
compared to 
background volume.         
 
% Adjusted Volume:
  
00.0-20.5: + 
20.5-40.5: + + 
40.5-60.5: + + +  
60.5-80.5: + + + + 
80.5-100: + + + + +    
No Chaperone
 
Tet Pellet 
pG-Tf2 
Tet Soluble 
 pG-Tf2 
Tet Pellet 
pG-KJE8 
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SN1 was a fresh colony while SN3 had been grown earlier and frozen until a later time. 
SN1 had a higher expression ratio (Pellet: 34.66 / Soluble: 1.75 ratio: 19.8) than the SN3 
colony which showed closer volumes in both the pellet and soluble fraction (Pellet: 24.3/ 
Soluble: 14.2 ratio: 1.71) 
Table 3. pG-Tf2 SN3 colony 
SN 3 COLONY 
Gel 1 
 
 
 
pG-Tf2 
Blank 
pG-Tf2 
No Chaperone 
pG-Tf2 
Tet induced 
pG-KJE8 
Tet induced 
PELLET -- + ++ ++ 
SOLUBLE -- + + -- 
 
(above) 
Expression  
strength of bands 
using adjusted 
volume from 
Western Blot test 
in the SN3 Colony 
of E. coli bacteria 
(left) Figure 3. 
Western Blot 
printout of the 
SN3 colony using 
QuantityOnecomp     
uter program to 
quantify the 
strength of    
expression compared  
to background volume.         
 
 
 
There was no expression seen in the soluble fraction when utilizing pG-Tf2 and 
tetracycline in combination with the other transcription factors. There was positive 
expression of ON1 and ON2 in the pellet but no expression was seen in the soluble 
fraction in either of these colonies.  
Tet Pellet 
pG-KJE8 
Tet Soluble 
pG-Tf2 Tet 
Pellet 
pG-Tf2 
No Chap 
Soluble 
No Chap 
Pellet 
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pG-KJE8 
When using the pG-KJE8 in conjunction with tetracycline there was no expression in the 
soluble fraction of any transcription factor although variable expression could be seen in 
both the SN1 and SN3 pellet. When tetracycline was used to induce expression in the 
remaining samples, SN1, ON, KN, and MN, there was no expression in the pellet or 
soluble fraction. Although there was no expression in these there was expression in the 
positive control which was run at the same time (see figure 4).  There was no expression 
in the SN1 colony in this gel, however, in a previous experiment there was positive pellet 
expression in the SN1 and SN3 colonies although this expression was highly variable 
with 23.92 and 49.57 respectively (see table 2 and table 3). 
Figure 4. Comparison of the lack of expression in the tetracycline induced pG-KJE8 
plasmid colonies and the positive expression in the control colony. 
 
 
 
 
 
 
 
      Test Colonies          Control Colony 
When induced with L-arabinose both SN1, SN3 and ON colonies showed positive results 
in the pellet and soluble fraction although there was more overall expression in SN1 than 
the ON colonies as seen in table 4 and figure 5 below. SN1 had a percent adjusted 
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volume in the pelleted fraction of 59.9 with the soluble fraction at 7.61 % for a ratio of 
7.87 (a comparison of ratios can be seen in table 6). SN3 had a pelleted volume of 31.61 
and a soluble fraction of 12.92 % with a ratio of 2.44. ON1 had a ratio of 1.18 with 
17.94% adjusted volume in the pellet and 15.20% adjusted volume in the soluble fraction.  
 
Table 4. pG-KJE8 induction with L-arabinose 
 
 SN1 ON1 KN1 MN1 
PELLET + + + + -- -- 
SOLUBLE + + -- -- 
above) Expression 
strength of bands 
using adjusted 
volume from 
Western Blot test in 
the pG-KJE8 
colonies induced 
with L-arabinose 
(left) Figure 5. 
Western Blot 
printout of the L-
arabinose induced 
colony using 
QuantityOne 
computer program 
to quantify the 
strength of  
          expression 
compared to  
background volume. 
 
The final condition tested was the combination of induction with both tetracycline and L-
arabinose to induce both the dnaK-dnaJ-grpE and groES-groEL chaperones. When both 
were used there was positive expression in the pellet for SN1, SN3, ON and KN, however 
SN1 
P 
SN1 
S 
ON1 
P 
ON1 
S 
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there was no positive expression for MN in either the pellet or soluble fraction. Pellet 
expression was relatively constant between the different transcription factors.  
Table 5.  pG-KJE8 induced with tetracycline and L-arabinose 
 ON1 SN KN MN 
PELLET + + + + + + + -- 
SOLUBLE -- -- -- -- 
 
Ratios:  
Table 6. Ratios of pellet to soluble fraction expression using percent adjusted volume 
 
SN1 pG-Tf2 
Tet Induced 
SN3 pG-Tf2 
Tet Induced 
SN1pG-KJE8 
L-Arabinose 
ON1pG-KJE8 
L-Arabinose 
PELLET 34.66 24.3 59.9 17.94 
SOLUBLE 1.75 14.2 7.61 15.20 
RATIO 19.81 1.71 7.81 1.18 
 
 
VII: Discussion: 
Embryonic stem cell research is still developing. Any increase in expression of 
the transcription factors which are known to play a key role in the maintenance of 
pluripotency in developing embryonic cells is a step towards further cloning and eventual 
medical applications of this research. There are many ethical arguments over the use of 
human embryos in research, but, by the ability to induce bacterial cells to express the 
proteins responsible for pluripotent and undifferentiated cells a patients own cells may 
eventually be used in their own treatment. Recently, four separate research groups have 
generated iPS cells from patients with a variety of neurodegenartive diseases including 
amyotrophic lateral sclerosis (Dimos et al., 2008) and Parkinson’s Disease (Soldner et al., 
2009). Researchers have also derived iPS cells from monkeys and rats and many are 
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looking to this as the future for drug discovery and the pharmacological industry 
(Yamanaka, 2009) 
There are many factors which can play a role in the overall expression which have 
yet to be tested. There are different ways to raise the bacterial colonies and this could 
effect how well they are able to produce the protein. This study used the minimum 
suggested amount of inducer which may play a vital role in the induction of the 
expression. Other research might include different chaperone plasmids that could 
increase the ability of the host to express the protein. Overall, the increased expression in 
any one of the transcription factors has great implications for further research and 
medical potential.  
Yamanaka (2009) highlighted many potential uses for the current research being 
conducted on iPS cells including their use in regenerative medicine. Although much 
research still needs to be completed before these discoveries can have human 
applications, Yamanaka (2009) points to their usefulness in eliminating patient rejection 
of a donor and the reduction of the ethical issues surrounding the use of a human embryo. 
In January 2009, the US Food and Drug Administration approved the first clinical trials 
to use human ES cells to treat human spinal cord injuries. With continued research there 
may be many more potential applications for this research.  
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Appendix 1 
IPTG Induction and  Extraction of Proteins from Bacteria 
Prepared by Swathi Arur and Sudhir Nayak 
  
 Induction in bacteria can be performed using one of two basic methods.  Fast 
induction does not work for all proteins and can give you suboptimal yields.  Slow 
induction can enhance the solubility of some proteins.  The method that's best for you 
will depend on your particular protein and the application.  If you want optimal solubility 
both should be tested before scaling up.  This protocol is generalized and will vary based 
on a variety of factors such as the bacterial strain, recombinant protein, and parent 
plasmid.  
  
Fast induction 
 1) From a relatively fresh plate (<4 weeks) pick a colony and grow O/N at 30deg 
C (or 37deg C) in 1-2ml LB+AMP(or other selection) in a 15ml snap cap tube on a 
rotator or shaker. 
 2) Dilute 1:50 (1:100 if 37deg O/N) in 2ml LB+AMP and grow 3-4 hours at 
37deg C in 15ml snap cap tube in a rotator. 
 4) Prepare 1ml LB+AMP+1mM IPTG in a 15ml conical and prewarm to 37dec C 
about 10min before use. 
 5) After 3-4hrs remove 1ml from tubes at 37deg C and place in labeled 1.5ml 
tubes.  Spin at max, 30sec, RT, and remove supe.  Freeze pellet at -20 until needed.  
THIS IS THE UNINDUCED CONTROL. 
 6) Add prewarmed 1ml LB+AMP+1mM IPTG to 15ml snap cap tube and return 
to 37 deg C for 3-4 hours.  This will get the final volume back to 2ml and the final 
concentration of IPTG to 0.5mM.   
 7) After 3-4hrs transfer 1ml from induced sample to labeled 1.5ml tubes and spin 
at max, 30sec, RT, and remove supe.  Freeze pellet at -20 until needed. THIS IS THE 
INDUCED SAMPLE. 
 8) Sample preparation for SDS-PAGE: Add 100ul of 1X loading buffer (see 
solutions below) with 1% BME to uninduced and induced samples.  Vortex for 10sec to 
1min or until there are no clumps of bacteria.  Boil 3-5min, spin at max, 30sec, RT, and 
load 5-25ul (usually 10ul) depending on gel (amount of protein, size of pellet, Western, 
etc.).   
  
Slow induction 
For slow induction of protein follow fast induction protocol with the following 
changes: 
6) Add 20deg 1ml LB+AMP+1mM IPTG to 15ml snap cap tube and incubate rotating or 
shaking at 20deg C for 12-16 hours.  This will get the final volume back to 2ml and the 
final concentration of IPTG to 0.5mM. 
7) After 12-16hrs transfer 1ml from induced sample to labeled 1.5ml tubes and spin at 
max, 30sec, RT, and remove supe.  Freeze pellet at -20 until needed. THIS IS THE 
INDUCED SAMPLE.  
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